Gastroenterology News

WASHINGTON — A time-trend analysis of colorectal cancer incidence over the past 20 years revealed an overall increase among individuals younger than 45 years, with a “disproportionate increase” among younger women vs. men.

WASHINGTON — The Primary Obesity Surgery Endoluminal 2.0 procedure is a “safe, effective and durable option” for weight loss and improvement in obesity-related conditions, according to a presenter.

WASHINGTON — Seladelpar use led to “rapid, marked and sustained improvement” in markers of cholestasis and liver injury among patients with primary biliary cholangitis, according to interim results of the ongoing, phase 3 ASSURE study.

Boehringer Ingelheim has partnered with Quallent Pharmaceuticals to expand access to its Humira biosimilar citrate-free adalimumab-adbm in the United States, according to a company press release.

In a Healio exclusive, Ari Grinspan, MD, predicted that while microbiota therapeutics are currently “not ready for prime time,” they will eventually become part of the treatment strategy for patients with inflammatory bowel disease.

DESTIN, Fla. — Pinpointing rare subtypes of Ehlers-Danlos syndrome is crucial, as the consequences of overlooking them could be deadly, according to a speaker at the Congress of Clinical Rheumatology East.

Treatment with Bylvay resulted in a “significantly greater” change from baseline to week 24 in mean scratching scores and serum bile acids vs. placebo among pediatric patients with Alagille syndrome, according to ASSERT study results.

Novel forms of a rare genetic variant may contribute to the risk for co-occurring Parkinson’s disease and inflammatory bowel disease, according to research presented in Genome Medicine.

During Hepatitis Awareness Month, the CDC and allied public health organizations launched educational campaigns to raise awareness of viral hepatitis, deflate stigma around the infection and encourage early testing and vaccination.

Most patients undergoing colonoscopy after diverticulitis had low risk for colorectal cancer, except those with complicated diverticulitis, whose risk was nearly four times greater than the screening population, according to research.